HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fasting apoprotein B-48 level and coronary artery disease in a population without frank fasting hypertriglyceridemia.

Abstract
The aim of this study was to test the hypothesis that fasting apoprotein B-48 level might be a surrogate marker of postprandial lipemia in evaluating the risk of coronary artery disease (CAD) in a population without frank abnormality in fasting lipid profile. One hundred twenty-three patients tested by coronary angiography were selected on the criteria of absence of treatment with hypolipidemic drugs, obvious hypertriglyceridemia (>2.85 mmol/L), or other conditions that may interfere with lipoprotein metabolism except diabetes. CAD was defined by more than 50% narrowing of vessel lumen, and its severity is determined by the number of arteries involved. Fasting apoprotein B-48 was measured by a competitive enzyme-linked immunosorbent assay method. There was no difference in fasting apoprotein B-48 levels between the groups with and without CAD (0.123+/-0.096 vs 0.136+/-0.125 microg/mL, respectively), whatever the sex or whether with or without diabetes. The apoprotein B-48 level was not related to the presence or the severity of CAD. There was also no correlation between fasting apoprotein B-48 levels and age, sex, body mass index, and usual fasting lipid parameters in both patients with and without angiographically proven CAD. Finally, among the features of metabolic syndrome, apoprotein B-48 was correlated with fasting triglyceride levels (r=0.357, P<.01) only. In conclusion, the present study shows that in the absence of any major fasting abnormality in plasma lipid parameters, fasting apoprotein B-48 level, which has been associated with postprandial hyperlipidemia, does not predict the risk of CAD.
AuthorsRené Valero, Anne-Marie Lorec, Franck Paganelli, Sophie Beliard, Catherine Atlan, Denis Lairon, Bernard Vialettes, Henri Portugal
JournalMetabolism: clinical and experimental (Metabolism) Vol. 54 Issue 11 Pg. 1442-7 (Nov 2005) ISSN: 0026-0495 [Print] United States
PMID16253631 (Publication Type: Journal Article)
Chemical References
  • Apolipoprotein B-48
  • Apolipoproteins B
  • Biomarkers
  • Triglycerides
  • Cholesterol
Topics
  • Aged
  • Apolipoprotein B-48
  • Apolipoproteins B (blood)
  • Biomarkers (blood)
  • Cholesterol (blood)
  • Coronary Artery Disease (epidemiology, metabolism)
  • Fasting
  • Female
  • Humans
  • Hypertriglyceridemia
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Risk Factors
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: